Importantly myeloid cells expressing the colony-stimulating factor-1 receptor (CSF-1R) (or TAM-CSF-1R+ cells) were recently found altered during the time-course of anti-GBM therapy. The gene discussed is CSF1R; the disease is glioblastoma.